Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prioritizing Discovery and Advancements in Arrhythmia Therapies: NIH/NHLBI Workshop.

JACC. Clinical electrophysiology·2026
Same author

2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Journal of the American College of Cardiology·2026
Same author

2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Circulation·2026
Same author

Ethical Considerations for Heart Organ Allocation: Current Landscape and Future Policy Guidance: A Scientific Statement From the American Heart Association.

Circulation·2026
Same author

Transforming Advanced Heart Failure Programs: Addressing Institutional and Systemic Drivers of Racial and Ethnic Disparities in Care.

Circulation. Heart failure·2026
Same author

Glucagon-like peptide-1 and atrial fibrillation incidence: Associations independent of weight loss.

Heart rhythm·2026
Same journal

Efficacy and safety of human albumin combined with furosemide in acute decompensated heart failure with hepatic dysfunction.

American heart journal·2026
Same journal

International study of Coronary Microvascular Angina (iCorMicA): a registry-based diagnostic study and nested randomized trial.

American heart journal·2026
Same journal

Stratified Medicine with Eplerenone for Myocardial Infarction or Injury and No obstructive Coronary Arteries: A Registry-Based Basket Trial.

American heart journal·2026
Same journal

Revised Lipid-Lowering Therapy Guidelines in a Nationally Representative Sample.

American heart journal·2026
Same journal

Cardiometabolic Health of Low- and Higher-Income Adults in the United States, 2009-2023.

American heart journal·2026
Same journal

Moving Beyond Technical Capability to Regulatory Integration for Digital Health Technology Devices-Brief Communication from the Cardiovascular Sciences Research Consortium.

American heart journal·2026
See all related articles

Related Experiment Video

Updated: Jul 4, 2025

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.5K

Characterizing advanced heart failure risk and hemodynamic phenotypes using interpretable machine learning.

Josephine Lamp1, Yuxin Wu2, Steven Lamp1

  • 1Department of Computer Science, University of Virginia, Charlottesville, VA.

American Heart Journal
|February 9, 2024
PubMed
Summary
This summary is machine-generated.

This study developed a novel machine learning model to accurately predict risk categories in advanced heart failure with reduced ejection fraction (HFrEF). The model integrates invasive hemodynamics and supports missing data, offering improved risk stratification for personalized treatment.

More Related Videos

Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
07:41

Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension

Published on: March 17, 2022

3.0K
Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
07:49

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach

Published on: July 21, 2023

1.4K

Related Experiment Videos

Last Updated: Jul 4, 2025

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.5K
Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
07:41

Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension

Published on: March 17, 2022

3.0K
Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
07:49

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach

Published on: July 21, 2023

1.4K

Area of Science:

  • Cardiology
  • Medical Informatics
  • Machine Learning

Background:

  • Existing risk models for advanced heart failure with reduced ejection fraction (HFrEF) often lack integration of invasive hemodynamics and robust handling of missing data.
  • This study addresses the need for advanced risk stratification tools in HFrEF management.

Purpose of the Study:

  • To develop and validate a heart failure (HF) hemodynamic risk and phenotyping score for HFrEF using interpretable Machine Learning (ML).
  • To predict patient risk categories (1-5) based on a composite endpoint, utilizing both invasive and comprehensive feature sets.

Main Methods:

  • Patients were categorized into 5 risk groups using unsupervised clustering based on a composite endpoint (death, LVAD, transplantation, rehospitalization within 6 months).
  • Interpretable ML models were developed to predict these risk categories using invasive hemodynamics or a comprehensive feature set including non-invasive data.
  • Models were trained on the ESCAPE trial data and validated across four additional advanced HF cohorts.

Main Results:

  • The developed ML models demonstrated high accuracy in predicting patient risk categories across all outcomes.
  • Prediction accuracies for risk categories ranged from 0.896 to 0.969 for the invasive hemodynamics set and 0.858 to 0.997 for the all features set.
  • The models proved robust to missing data, enhancing their clinical applicability.

Conclusions:

  • Novel interpretable ML models accurately predict distinct risk categories in HFrEF, offering a new paradigm beyond binary outcome prediction.
  • This approach facilitates nuanced risk stratification, potentially guiding personalized treatment selection for advanced HF patients.
  • Further prospective clinical evaluation is recommended to ascertain the utility of this risk stratification method in clinical practice.